This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
Ricin beta Monoclonal Antibody (RB999)
catalog :
MA1-74237
quantity :
200 µg
price :
US 405.00
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
RB999
application :
western blot, ELISA
product information
Product Type :
Antibody
Product Name :
Ricin beta Monoclonal Antibody (RB999)
Catalog # :
MA1-74237
Quantity :
200 µg
Price :
US 405.00
Clonality :
Monoclonal
Purity :
Protein G
Host :
Mouse
Reactivity :
Plant
Applications :
ELISA: Assay-dependent, Western Blot: Assay-dependent
Species :
Plant
Clone :
RB999
Isotype :
IgG1
Storage :
4°C or -20°C if preferred
Description :
Ricin toxin is a 60 kDa glycoprotein that consists of two chains, A and B, covalently linked by a disulfide bond. The A chain acts as a glycosidase that removes an adenine residue from the 28S rRNA. The area from which the adenine is removed is essential for binding of elongation factors, destroying it leaves the ribosome inactive and unable to support protein synthesis. The A chain can inactivate a few thousand ribosomes per minute, much faster than the cell can replace them, meaning that a single ricin A chain can kill a cell. The B chain binds to complex carbohydrates on the cell surface to facilitate entry of the A chain into the cell. Without the B chain, the A chain has very low toxicity. Ricin is easily extracted from the castor bean (Ricinus communis), and the lethal dose for humans is very small. It is toxic when inhaled, ingested or injected and there is no known antidote, although a vaccine has been developed. Treatment is symptomatic and supportive, with long term organ damage likely in survivors. The ease of extraction and distribution makes it a potential candidate for biological warfare although it is less stable than other agents, such as anthrax.
Immunogen :
Proprietary sequence
Format :
Liquid
Applications w/Dilutions :
ELISA: Assay-dependent, Western Blot: Assay-dependent
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com
800-678-5599
headquarters: USA